CompletedNCT03822416
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Depression
CompletedNCT02974010
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can better prevent setbacks and support longer-term stability.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- NeuroRx, Inc.
- Condition
- Depression
CompletedNCT03918954
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
DepressionOtherOver 18 Years
- Countries
- Sweden
- Sponsor
- Vastra Gotaland Region
- Condition
- Depression
CompletedNCT00666432
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 15 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT01948024
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Sun Pharmaceutical Industries Limited
- Condition
- Schizophrenia
CompletedNCT03658824
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
DepressionOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Exeter
- Condition
- Depression
CompletedNCT04855409
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- Mehmet Diyaddin Güleken
- Condition
- Depression
CompletedNCT03404882
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Alberta
- Condition
- Schizophrenia
CompletedNCT00312494
This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00282464
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Depression
TerminatedNCT00329108
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Germany, Greece, Italy, Spain, Turkey
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT03050853
This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Schizophrenia
CompletedNCT00141271
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Depression
CompletedNCT00265330
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00280566
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Chile, France, Germany, Guatemala, China, India, Italy, Mexico, Russian Federation, Spain, Taiwan, United States, Venezuela
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT00055575
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Depression
CompletedNCT03965871
This study exists to compare options and see whether the medication Inhaled offers something meaningfully different. Researchers are trying to understand whether the medication Inhaled can give earlier or clearer feedback during care.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Poland
- Sponsor
- Celon Pharma SA
- Condition
- Depression
TerminatedNCT03562520
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 13 Years to 21 Years
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
- Condition
- Bipolarity
CompletedNCT01431573
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Depression
CompletedNCT00483548
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
DepressionOtherOver 18 Years
- Countries
- Australia, India, United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Depression
CompletedNCT01053429
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOther
- Countries
- Global
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Schizophrenia
CompletedNCT00257166
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
TerminatedNCT01113541
This study exists to explore whether the medication Oral could improve care and understanding. Researchers are trying to understand how people respond to the medication Oral in practice and what may need to be adjusted.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
WithdrawnNCT03764683
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
DepressionOtherFrom 18 Years to 75 Years
- Countries
- Global
- Sponsor
- Massachusetts General Hospital
- Condition
- Depression
WithdrawnNCT01124877
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
BipolarityOtherFrom 10 Years to 17 Years
- Countries
- Global
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity